SIG 24.9% $2.43 sigma healthcare limited

Ann: Sigma 2018/19 Half Year Results Presentation, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,624 Posts.
    lightbulb Created with Sketch. 100
    We are on track to meet FY19 guidance of Underlying EBIT of $75 million, with the 2H19 set to benefit from cost savings already achieved in the business.”

    “Sales Revenue for the six months was down 2.0% to $1.96 billion, largely impacted by the decline in low margin Hepatitis C medications and some impact from the up-scheduling of codeine-based products from February. Excluding Hepatitis C alone, sales revenue was up 3.2% to $1.82 billion.”

    The Hep C meds impact and up-schedule of codeine is affecting all wholesalers, including EBOS.
    However, excluding Hep C, good to see sales revenue up 3.2%.
 
watchlist Created with Sketch. Add SIG (ASX) to my watchlist
(20min delay)
Last
$2.43
Change
0.485(24.9%)
Mkt cap ! $2.300B
Open High Low Value Volume
$2.52 $2.70 $2.32 $138.1M 55.83M

Buyers (Bids)

No. Vol. Price($)
5 123400 $2.42
 

Sellers (Offers)

Price($) Vol. No.
$2.44 1365 1
View Market Depth
Last trade - 16.10pm 07/11/2024 (20 minute delay) ?
SIG (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.